Sarepta Therapeutics, Inc.
MX ˙ BMV ˙ US8036071004
SecurityMX:SRPT / Sarepta Therapeutics, Inc.
InstitutionJpmorgan Chase & Co
Latest Disclosed Ownership703,191 shares
Latest Disclosed Value $ 14,401,351
Jpmorgan Chase & Co ownership in SRPT / Sarepta Therapeutics, Inc.

On May 13, 2026 - Jpmorgan Chase & Co filed a 13F-HR/A form disclosing ownership of 703,191 shares of Sarepta Therapeutics, Inc. (MX:SRPT) valued at $14,401,351 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 743,988 shares of Sarepta Therapeutics, Inc.. This represents a change in shares of -5.48% during the quarter.

Jpmorgan Chase & Co has a history of taking positions in derivatives of the underlying security (SRPT) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:SRPT / Sarepta Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 SAREPTA THERAPEUTICS COMMON 803607100 703,191 -40,797 -5.48 14,401 -10.05 0.0001
2026-05-13 2026-03-31 13F SAREPTA THERAPEUTICS COMMON 803607100 250,000 -493,988 5,120 0.1659
2026-02-11 2025-12-31 13F SAREPTA THERAPEUTICS COMMON 803607100 743,988 74,606 11.15 16,011 24.12 0.0010
2025-11-26 2025-09-30 13F/A-1 SAREPTA THERAPEUTICS COMMON 803607100 669,382 17,183 2.63 12,899 15.67 0.0008
2025-11-07 2025-09-30 13F SAREPTA THERAPEUTICS COMMON 803607100 669,382 17,183 12,899 0.0001
2025-08-12 2025-06-30 13F SAREPTA THERAPEUTICS COMMON 803607100 652,199 -1,592,233 -70.94 11,153 -92.21 0.0007
2025-05-12 2025-03-31 13F SAREPTA THERAPEUTICS COMMON 803607100 2,244,432 223,828 11.08 143,240 -41.70 0.0105
2025-02-12 2024-12-31 13F SAREPTA THERAPEUTICS COMMON 803607100 2,020,604 -178,279 -8.11 245,685 -10.54 0.0183
2024-12-26 2024-09-30 13F/A-1 SAREPTA THERAPEUTICS COMMON 803607100 2,198,883 355,114 19.26 274,618 -5.73 0.0209
2024-11-08 2024-09-30 13F SAREPTA THERAPEUTICS COMMON 803607100 2,198,883 355,114 274,618 0.0209
2024-12-26 2024-06-30 13F/A-1 SAREPTA THERAPEUTICS COMMON 803607100 1,843,769 15,167 0.83 291,316 23.06 0.0239
2024-08-12 2024-06-30 13F SAREPTA THERAPEUTICS COMMON 803607100 1,843,769 15,167 291,316 0.0239
2024-12-26 2024-03-31 13F/A-1 SAREPTA THERAPEUTICS COMMON 803607100 1,828,602 526,045 40.39 236,731 88.47 0.0200
2024-05-10 2024-03-31 13F SAREPTA THERAPEUTICS COMMON 803607100 1,828,602 526,045 236,731 0.0200
2024-12-26 2023-12-31 13F/A-1 SAREPTA THERAPEUTICS COMMON 803607100 1,302,557 -3,305,758 -71.73 125,606 -77.52 0.0120
2024-02-12 2023-12-31 13F SAREPTA THERAPEUTICS COMMON 803607100 1,302,557 -3,305,758 125,606 0.0121
2023-11-14 2023-09-30 13F SAREPTA THERAPEUTICS COM 803607100 4,608,315 204,222 4.64 558,620 10.76 0.0616
2023-08-11 2023-06-30 13F SAREPTA THERAPEUTICS COMMON 803607100 4,404,093 701,149 18.93 504,357 -1.18 0.0548
2023-05-18 2023-03-31 13F/A-1 SAREPTA THERAPEUTICS COMMON 803607100 3,702,944 2,459,497 197.80 510,376 316,903.73 0.0622
2023-05-11 2023-03-31 13F SAREPTA THERAPEUTICS COMMON 803607100 3,653,895 2,410,448 510,376 0.0076
2023-02-13 2022-12-31 13F SAREPTA THERAPEUTICS COMMON 803607100 1,243,447 522,434 72.46 161 -99.80 0.0212
2022-11-14 2022-09-30 13F SAREPTA THERAPEUTICS COMMON 803607100 721,013 -302,735 -29.57 79,700 3.86 0.0114
2022-08-11 2022-06-30 13F SAREPTA THERAPEUTICS COMMON 803607100 1,023,748 -66,918 -6.14 76,741 -9.93 0.0107
2022-05-11 2022-03-31 13F SAREPTA THERAPEUTICS COMMON 803607100 1,090,666 42,043 4.01 85,202 -9.77 0.0103
2022-02-11 2021-12-31 13F/A-1 SAREPTA THERAPEUTICS COMMON 803607100 1,048,623 -464,780 -30.71 94,429 -32.53 0.0109
2022-02-10 2021-12-31 13F SAREPTA THERAPEUTICS COMMON 803607100 1,048,623 -464,780 94,429 0.0016
2021-11-12 2021-09-30 13F SAREPTA THERAPEUTICS COMMON 803607100 1,513,403 207,061 15.85 139,959 37.82 0.0173
2021-08-12 2021-06-30 13F SAREPTA THERAPEUTICS COMMON 803607100 1,306,342 552,744 73.35 101,555 80.81 0.0121
2021-05-12 2021-03-31 13F SAREPTA THERAPEUTICS COMMON 803607100 753,598 -1,001 -0.13 56,166 -56.34 0.0075
2021-02-19 2020-12-31 13F/A-1 SAREPTA THERAPEUTICS COMMON 803607100 754,599 -371,910 -33.01 128,651 -19.17 0.0189
2021-02-11 2020-12-31 13F SAREPTA THERAPEUTICS COMMON 803607100 754,599 -371,910 128,651 3,181.6309
2020-11-12 2020-09-30 13F/A-1 SAREPTA THERAPEUTICS COMMON 803607100 1,126,509 -451,404 -28.61 159,153 -37.09 0.0267
2020-11-12 2020-09-30 13F SAREPTA THERAPEUTICS COMMON 803607100 1,126,509 159,153
2020-08-11 2020-06-30 13F SAREPTA THERAPEUTICS COMMON 803607100 1,577,913 433,450 37.87 253,003 125.99 0.0488
2020-05-12 2020-03-31 13F SAREPTA THERAPEUTICS COMMON 803607100 1,144,463 207,113 22.10 111,951 -7.45 0.0263
2020-02-11 2019-12-31 13F SAREPTA THERAPEUTICS COMMON 803607100 937,350 833,885 805.96 120,958 1,451.74 0.0226
2019-11-12 2019-09-30 13F SAREPTA THERAPEUTICS COMMON 803607100 103,465 5,605 5.73 7,795 -38.62 0.0016
2019-08-07 2019-06-30 13F SAREPTA THERAPEUTICS COMMON 803607100 97,860 -116,586 -54.37 12,699 -50.32 0.0025
2019-05-07 2019-03-31 13F SAREPTA THERAPEUTICS COMMON 803607100 214,446 9,146 4.45 25,561 14.09 0.0052
2019-02-11 2018-12-31 13F SAREPTA THERAPEUTICS COMMON 803607100 205,300 119,377 138.93 22,404 61.44 0.0052
2018-11-13 2018-09-30 13F/A-1 SAREPTA THERAPEUTICS COMMON 803607100 85,923 -115,038 -57.24 13,878 -47.76 0.0027
2018-11-07 2018-09-30 13F SAREPTA THERAPEUTICS COMMON 803607100 85,923 -115,038 13,878
2018-08-14 2018-06-30 13F SAREPTA THERAPEUTICS COMMON 803607100 200,961 -508,109 -71.66 26,564 -49.44 0.0055
2018-05-10 2018-03-31 13F SAREPTA THERAPEUTICS COMMON 803607100 709,070 273,841 62.92 52,535 116.93 0.0113
2018-02-13 2017-12-31 13F SAREPTA THERAPEUTICS COMMON 803607100 435,229 117,429 36.95 24,217 61.62 0.0051
2017-11-09 2017-09-30 13F SAREPTA THERAPEUTICS COMMON 803607100 317,800 41,975 15.22 14,984 61.15 0.0033
2017-08-09 2017-06-30 13F SAREPTA THERAPEUTICS COMMON 803607100 275,825 114,300 70.76 9,298 94.48 0.0021
2017-05-10 2017-03-31 13F SAREPTA THERAPEUTICS COMMON 803607100 161,525 98,025 154.37 4,781 174.45 0.0011
2017-02-06 2016-12-31 13F SAREPTA THERAPEUTICS COMMON 803607100 63,500 -5,000 -7.30 1,742 -58.59 0.0004
2016-11-04 2016-09-30 13F SAREPTA THERAPEUTICS COMMON 803607100 68,500 67,930 11,917.54 4,207 38,145.45 0.0010
2016-08-08 2016-06-30 13F SAREPTA THERAPEUTICS COMMON 803607100 570 -4,364 -88.45 11 -88.54 0.0000
2016-05-10 2016-03-31 13F SAREPTA THERAPEUTICS COMMON 803607100 4,934 385 8.46 96 -45.45 0.0000
2016-02-12 2015-12-31 13F SAREPTA THERAPEUTICS COMMON 803607100 4,549 4,549 -73.20 176 -78.03 0.0000
2014-02-26 2013-12-31 13F/A-1 SAREPTA THERAPEUTICS COMMON 803607100 0 -16,973 -100.00 0 -100.00
2013-10-31 2013-09-30 13F SAREPTA THERAPEUTICS COMMON 803607100 16,973 -8,927 -34.47 801 -18.76 0.0002
2013-08-13 2013-06-30 13F SAREPTA THERAPEUTICS COMMON 803607100 25,900 25,900 986 0.0003
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A SAREPTA THERAPEUTICS OPTION Call 0 -100.00 0 -100.00 n/a n/a n/a
2026-05-13 2026-03-31 13F SAREPTA THERAPEUTICS OPTION Call 0 0 n/a n/a n/a
2026-02-11 2025-12-31 13F SAREPTA THERAPEUTICS OPTION Call 108,600 -50.43 2,337 -44.65 n/a n/a n/a
2025-11-26 2025-09-30 13F/A SAREPTA THERAPEUTICS OPTION Call 219,100 106.11 4,222 132.36 n/a n/a n/a
2025-11-07 2025-09-30 13F SAREPTA THERAPEUTICS OPTION Call 219,100 4,222 n/a n/a n/a
2025-08-12 2025-06-30 13F SAREPTA THERAPEUTICS OPTION Call 106,300 93.27 1,818 -48.23 n/a n/a n/a
2025-05-12 2025-03-31 13F SAREPTA THERAPEUTICS OPTION Call 55,000 -43.59 3,510 -70.39 n/a n/a n/a
2025-02-12 2024-12-31 13F SAREPTA THERAPEUTICS OPTION Call 97,500 69.57 11,855 65.09 n/a n/a n/a
2024-12-26 2024-09-30 13F/A SAREPTA THERAPEUTICS OPTION Call 57,500 28,650.00 7,181 23,064.52 n/a n/a n/a
2024-11-08 2024-09-30 13F SAREPTA THERAPEUTICS OPTION Call 57,500 7,181 n/a n/a n/a
2024-12-26 2024-06-30 13F/A SAREPTA THERAPEUTICS OPTION Call 200 -99.61 32 -99.53 n/a n/a n/a
2024-08-12 2024-06-30 13F SAREPTA THERAPEUTICS OPTION Call 200 32 n/a n/a n/a
2024-12-26 2024-03-31 13F/A SAREPTA THERAPEUTICS OPTION Call 51,200 -91.91 6,628 -89.14 n/a n/a n/a
2024-05-10 2024-03-31 13F SAREPTA THERAPEUTICS OPTION Call 51,200 6,628 n/a n/a n/a
2024-12-26 2023-12-31 13F/A SAREPTA THERAPEUTICS OPTION Call 633,000 -4.35 61,040 -23.91 n/a n/a n/a
2024-02-12 2023-12-31 13F SAREPTA THERAPEUTICS OPTION Call 633,000 61,040 n/a n/a n/a
2023-11-14 2023-09-30 13F SAREPTA THERAPEUTICS OPTION Call 661,800 8,384.62 80,223 8,883.54 n/a n/a n/a
2023-08-11 2023-06-30 13F SAREPTA THERAPEUTICS OPTION Call 7,800 -97.91 893 -98.27 n/a n/a n/a
2023-05-18 2023-03-31 13F/A SAREPTA THERAPEUTICS OPTION Call 374,100 34.38 51,562 143,127.78 n/a n/a n/a
2023-05-11 2023-03-31 13F SAREPTA THERAPEUTICS OPTION Call 374,100 51,562 n/a n/a n/a
2023-02-13 2022-12-31 13F SAREPTA THERAPEUTICS OPTION Call 278,400 378.35 36 -99.44 n/a n/a n/a
2022-11-14 2022-09-30 13F SAREPTA THERAPEUTICS OPTION Call 58,200 6,433 n/a n/a n/a
2022-08-11 2022-06-30 13F SAREPTA THERAPEUTICS OPTION Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-11 2022-03-31 13F SAREPTA THERAPEUTICS OPTION Call 50,100 -87.61 3,914 -89.25 n/a n/a n/a
2022-02-11 2021-12-31 13F/A SAREPTA THERAPEUTICS OPTION Call 404,400 102.20 36,416 96.89 n/a n/a n/a
2022-02-10 2021-12-31 13F SAREPTA THERAPEUTICS OPTION Call 404,400 36,416 n/a n/a n/a
2021-11-12 2021-09-30 13F SAREPTA THERAPEUTICS OPTION Call 200,000 18,496 n/a n/a n/a
2021-05-12 2021-03-31 13F SAREPTA THERAPEUTICS OPTION Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-19 2020-12-31 13F/A SAREPTA THERAPEUTICS OPTION Call 30,000 140.00 5,115 189.64 n/a n/a n/a
2021-02-11 2020-12-31 13F SAREPTA THERAPEUTICS OPTION Call 30,000 5,115 n/a n/a n/a
2020-11-12 2020-09-30 13F/A SAREPTA THERAPEUTICS OPTION Call 12,500 1,766 n/a n/a n/a
2020-11-12 2020-09-30 13F SAREPTA THERAPEUTICS OPTION Call 12,500 1,766 n/a n/a n/a
2020-05-12 2020-03-31 13F SAREPTA THERAPEUTICS OPTION Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-11 2019-12-31 13F SAREPTA THERAPEUTICS OPTION Call 144,100 92.90 18,595 230.52 n/a n/a n/a
2019-11-12 2019-09-30 13F SAREPTA THERAPEUTICS OPTION Call 74,700 -79.83 5,626 -88.29 n/a n/a n/a
2019-08-07 2019-06-30 13F SAREPTA THERAPEUTICS OPTION Call 370,400 69.36 48,063 84.38 n/a n/a n/a
2019-05-07 2019-03-31 13F SAREPTA THERAPEUTICS OPTION Call 218,700 710.00 26,067 784.53 n/a n/a n/a
2019-02-11 2018-12-31 13F SAREPTA THERAPEUTICS OPTION Call 27,000 -38.64 2,947 -58.53 n/a n/a n/a
2018-11-13 2018-09-30 13F/A SAREPTA THERAPEUTICS OPTION Call 44,000 -2.22 7,106 19.47 n/a n/a n/a
2018-11-07 2018-09-30 13F SAREPTA THERAPEUTICS OPTION Call 44,000 7,106 n/a n/a n/a
2018-08-14 2018-06-30 13F SAREPTA THERAPEUTICS OPTION Call 45,000 5,948 n/a n/a n/a
2018-05-10 2018-03-31 13F SAREPTA THERAPEUTICS OPTION Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-13 2017-12-31 13F SAREPTA THERAPEUTICS OPTION Call 85,000 24.09 4,729 46.41 n/a n/a n/a
2017-11-09 2017-09-30 13F SAREPTA THERAPEUTICS OPTION Call 68,500 3,230 n/a n/a n/a
2017-05-10 2017-03-31 13F SAREPTA THERAPEUTICS OPTION Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-06 2016-12-31 13F SAREPTA THERAPEUTICS OPTION Call 20,000 549 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A SAREPTA THERAPEUTICS OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2026-05-13 2026-03-31 13F SAREPTA THERAPEUTICS OPTION Put 0 0 n/a n/a n/a
2026-02-11 2025-12-31 13F SAREPTA THERAPEUTICS OPTION Put 195,100 -24.20 4,199 -15.36 n/a n/a n/a
2025-11-26 2025-09-30 13F/A SAREPTA THERAPEUTICS OPTION Put 257,400 114.50 4,960 141.72 n/a n/a n/a
2025-11-07 2025-09-30 13F SAREPTA THERAPEUTICS OPTION Put 257,400 4,960 n/a n/a n/a
2025-08-12 2025-06-30 13F SAREPTA THERAPEUTICS OPTION Put 120,000 71.43 2,052 -54.06 n/a n/a n/a
2025-05-12 2025-03-31 13F SAREPTA THERAPEUTICS OPTION Put 70,000 0.00 4,467 -47.51 n/a n/a n/a
2025-02-12 2024-12-31 13F SAREPTA THERAPEUTICS OPTION Put 70,000 -53.33 8,511 -54.57 n/a n/a n/a
2024-12-26 2024-09-30 13F/A SAREPTA THERAPEUTICS OPTION Put 150,000 18,734 n/a n/a n/a
2024-11-08 2024-09-30 13F SAREPTA THERAPEUTICS OPTION Put 150,000 18,734 n/a n/a n/a
2024-08-12 2024-06-30 13F SAREPTA THERAPEUTICS OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-12-26 2024-03-31 13F/A SAREPTA THERAPEUTICS OPTION Put 55,000 -74.70 7,120 -66.04 n/a n/a n/a
2024-05-10 2024-03-31 13F SAREPTA THERAPEUTICS OPTION Put 55,000 7,120 n/a n/a n/a
2024-12-26 2023-12-31 13F/A SAREPTA THERAPEUTICS OPTION Put 217,400 177.65 20,964 120.87 n/a n/a n/a
2024-02-12 2023-12-31 13F SAREPTA THERAPEUTICS OPTION Put 217,400 20,964 n/a n/a n/a
2023-11-14 2023-09-30 13F SAREPTA THERAPEUTICS OPTION Put 78,300 125.00 9,492 138.17 n/a n/a n/a
2023-08-11 2023-06-30 13F SAREPTA THERAPEUTICS OPTION Put 34,800 -3.33 3,985 -19.69 n/a n/a n/a
2023-05-18 2023-03-31 13F/A SAREPTA THERAPEUTICS OPTION Put 36,000 380.00 4,962 n/a n/a n/a
2023-05-11 2023-03-31 13F SAREPTA THERAPEUTICS OPTION Put 36,000 4,962 n/a n/a n/a
2023-02-13 2022-12-31 13F SAREPTA THERAPEUTICS OPTION Put 7,500 -17.58 1 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F SAREPTA THERAPEUTICS OPTION Put 9,100 1,006 n/a n/a n/a
2022-08-11 2022-06-30 13F SAREPTA THERAPEUTICS OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-11 2022-03-31 13F SAREPTA THERAPEUTICS OPTION Put 100,000 -42.36 7,812 -50.00 n/a n/a n/a
2022-02-11 2021-12-31 13F/A SAREPTA THERAPEUTICS OPTION Put 173,500 -54.69 15,624 -55.88 n/a n/a n/a
2022-02-10 2021-12-31 13F SAREPTA THERAPEUTICS OPTION Put 173,500 15,624 n/a n/a n/a
2021-11-12 2021-09-30 13F SAREPTA THERAPEUTICS OPTION Put 382,900 35,411 n/a n/a n/a
2021-05-12 2021-03-31 13F SAREPTA THERAPEUTICS OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-19 2020-12-31 13F/A SAREPTA THERAPEUTICS OPTION Put 417,600 15,961.54 71,197 19,299.73 n/a n/a n/a
2021-02-11 2020-12-31 13F SAREPTA THERAPEUTICS OPTION Put 417,600 71,197 n/a n/a n/a
2020-11-12 2020-09-30 13F/A SAREPTA THERAPEUTICS OPTION Put 2,600 367 n/a n/a n/a
2020-11-12 2020-09-30 13F SAREPTA THERAPEUTICS OPTION Put 2,600 367 n/a n/a n/a
2020-05-12 2020-03-31 13F SAREPTA THERAPEUTICS OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-11 2019-12-31 13F SAREPTA THERAPEUTICS OPTION Put 47,600 6,142 n/a n/a n/a
2019-11-12 2019-09-30 13F SAREPTA THERAPEUTICS OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-07 2019-06-30 13F SAREPTA THERAPEUTICS OPTION Put 29,500 -18.73 3,828 -11.53 n/a n/a n/a
2019-05-07 2019-03-31 13F SAREPTA THERAPEUTICS OPTION Put 36,300 34.44 4,327 46.83 n/a n/a n/a
2019-02-11 2018-12-31 13F SAREPTA THERAPEUTICS OPTION Put 27,000 -38.64 2,947 -58.53 n/a n/a n/a
2018-11-13 2018-09-30 13F/A SAREPTA THERAPEUTICS OPTION Put 44,000 -78.22 7,106 -73.39 n/a n/a n/a
2018-11-07 2018-09-30 13F SAREPTA THERAPEUTICS OPTION Put 44,000 7,106 n/a n/a n/a
2018-08-14 2018-06-30 13F SAREPTA THERAPEUTICS OPTION Put 202,000 26,700 n/a n/a n/a
2018-02-13 2017-12-31 13F SAREPTA THERAPEUTICS OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-09 2017-09-30 13F SAREPTA THERAPEUTICS OPTION Put 101,000 4,762 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.